Cancer Health Treatment Update Big Gains in Bone Marrow Transplant Survival Since the Mid-2000s Despite patients being older and sicker, the mortality rate dropped by one-third within a 10-year period. What People With Cancer Need to Know About the New Coronavirus New research is emerging about how the respiratory virus spreads and how people can protect themselves and others. Major Cancer Drug Trials Are Woefully Lacking in Cardiovascular Data Nearly two in five major late-stage cancer drug trials did not report cardiovascular side effects at all. FDA Approves Sarclisa for People With Previously Treated Multiple Myeloma Approval was based on a study showing combination treatment reduced disease progression or death by 40%. Gay & Bi Men Have an Elevated Skin Cancer Rate Researchers think that higher use of tanning beds may drive this difference between gay and bisexual men and heterosexuals. Genitourinary Cancers Symposium 2020 See all our conference coverage about prostate, bladder and kidney cancers. Cancer Health Winter 2020 Check out our latest print edition! Advertisement Newsfeed Major Cancer Drug Trials Are Woefully Lacking in Cardiovascular Data Task Force: Test All Adults for Hepatitis C Nine Americans Die of Novel Coronavirus Does Having Cancer Once Increase the Risk of Developing Other Cancers? Blog: National Cancer Institute Artificial Intelligence Expedites Brain Tumor Diagnosis During Surgery Is Proton Therapy Safer Than Traditional Radiation? Ayvakit Approved to Treat GIST With a Rare Gene Alteration Single-Cell Metabolic Analyses of the Tumor Microenvironment Newsfeed Major Cancer Drug Trials Are Woefully Lacking in Cardiovascular Data Task Force: Test All Adults for Hepatitis C Nine Americans Die of Novel Coronavirus Does Having Cancer Once Increase the Risk of Developing Other Cancers? Blog: National Cancer Institute Artificial Intelligence Expedites Brain Tumor Diagnosis During Surgery Is Proton Therapy Safer Than Traditional Radiation? Ayvakit Approved to Treat GIST With a Rare Gene Alteration Single-Cell Metabolic Analyses of the Tumor Microenvironment

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: